These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25794477)

  • 1. Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
    Mayol L; Serri C; Menale C; Crispi S; Piccolo MT; Mita L; Giarra S; Forte M; Saija A; Biondi M; Mita DG
    Eur J Pharm Biopharm; 2015 Jun; 93():37-45. PubMed ID: 25794477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances.
    Serri C; Argirò M; Piras L; Mita DG; Saija A; Mita L; Forte M; Giarra S; Biondi M; Crispi S; Mayol L
    Int J Pharm; 2017 Mar; 520(1-2):21-28. PubMed ID: 28130197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
    Verderio P; Bonetti P; Colombo M; Pandolfi L; Prosperi D
    Biomacromolecules; 2013 Mar; 14(3):672-82. PubMed ID: 23350530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.
    Dalpiaz A; Contado C; Mari L; Perrone D; Pavan B; Paganetto G; Hanuskovà M; Vighi E; Leo E
    Drug Deliv; 2014 May; 21(3):221-32. PubMed ID: 24134683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
    Tabatabaei Mirakabad FS; Akbarzadeh A; Milani M; Zarghami N; Taheri-Anganeh M; Zeighamian V; Badrzadeh F; Rahmati-Yamchi M
    Artif Cells Nanomed Biotechnol; 2016; 44(1):423-30. PubMed ID: 25229832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
    Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
    J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
    J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
    Girotra P; Singh SK; Kumar G
    Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
    Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line.
    Chopra D; Ray L; Dwivedi A; Tiwari SK; Singh J; Singh KP; Kushwaha HN; Jahan S; Pandey A; Gupta SK; Chaturvedi RK; Pant AB; Ray RS; Gupta KC
    Biomaterials; 2016 Apr; 84():25-41. PubMed ID: 26803409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
    Feng R; Zhang Z; Li Z; Huang G
    Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.